MedPath
HSA Approval

ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML

SIN15562P

ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML

ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML

October 3, 2018

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

M05BA08

zoledronic acid

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

Sun Pharmaceutical Industries Limited

Active Ingredients

Zoledronic Acid monohydrate 4.264 mg equivalent to Zoledronic acid (anhydrous basis)

4.00mg/5ml

Zoledronic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.